Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Leadership

Part 1: A Transformation Agenda

Don't ask patients, "What's the matter with you?" Ask patients, "What matters to you?"

Chief Transformation Officer, SSM Health
Chairman and CEO, Navvis
Principal, Oliver Wyman

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Oliver Wyman

Thanks to AI, organizations’ quarterly endeavors have now become daily tasks.

Former President, Global Credit Risk and Information Management, American Express
CEO, Health Evolution
Partner, Health & Life Sciences, Oliver Wyman

Memorable highlights from the seventh annual Oliver Wyman Health Innovation Summit.

Oliver Wyman's research findings on diversity in healthcare leadership (some of which surprised us).

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Engagement Manager, Oliver Wyman
Principal, Oliver Wyman
Consultant

Insights in your inbox

Subscribe

Executives must create the future, boldly. How? Just channel your inner Einstein.

Senior Partner, Innovation, Lippincott

Interview with BlueCare Tennessee's Amber Cambron

This holistic, collaborative approach for a diverse population considers patients like extended family.

President & CEO, BlueCare Tennessee

Hospital leaders share their biggest hopes and fears for an industry in transformation.

President and CEO, Dallas-Fort Worth Hospital Council
Chief Strategy Officer, Baylor Scott & White Health
CEO, Texas Health Resources
President and CEO, Henry Ford Health System

Ten ways breaking one big project into many projects decreases risk and increases pace of innovation.

Managing Director, BNY Mellon, Former Partner, Oliver Wyman

Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe